"WASHINGTON, DC â€” The Micra Transcatheter Pacing System by Medtronic has become the first leadless pacemaker system to be approved in the United States. The US Food and Drug Administration (FDA) announced the approval almost 2 months afte"...
Cardiogen-82 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Cardiogen-82 (rubidium Rb 82 generator) is a diagnostic aid used for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. Common side effects of Cardiogen-82 include unintended radiation exposure. Induction of cardiovascular stress can be associated with serious heart and breathing problems.
The recommended adult single dose of Cardiogen-82 injection is 1480 MBq (40 mCi) with a range of 1110-2220 MBq (30-60 mCi). Cardiogen-82 may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Cardiogen-82 should be used only if prescribed. It is unknown if this drug passes into breast milk. Due to the short half-life of rubidium Rb-82 (75 seconds) it is unlikely the drug would be excreted in breast milk during lactation. Do not resume breastfeeding until one hour after the last infusion. Consult your doctor before breastfeeding.
Our Cardiogen-82 (rubidium Rb 82 generator) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Cardiogen-82 FDA Prescribing Information: Side Effects
The following serious adverse reactions have been identified during postapproval use of CardioGen-82. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Unintended radiation exposure has occurred in some patients who received rubidium Rb 82 chloride injections at clinical sites where generator eluate testing appeared insufficient [see BOXED WARNING, WARNINGS AND PRECAUTIONS, and DOSAGE AND ADMINISTRATION].
Read the entire FDA prescribing information for Cardiogen-82 (rubidium Rb 82 generator)
Additional Cardiogen-82 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.